CAR-T Cell Therapy:
The Future of Precision Immunotherapy
Discover how engineered T cells and advanced CAR-T technologies are transforming autoimmune research through targeted immune cell modulation, immune tolerance restoration, and next-generation cellular engineering.
Explore CAR-T TechnologyWhat is CAR-T Cell Therapy?
CAR-T (Chimeric Antigen Receptor T cell) technology modifies a patient's own T cells to recognize specific cellular targets. These engineered immune cells are designed to identify and remove harmful immune populations, creating a more precise approach compared with broad immune suppression.
Why CAR-T for Autoimmune Research?
Autoreactive B Cells
CAR-T approaches can selectively target immune cells responsible for abnormal immune activation.
Plasma Cell Targeting
Advanced strategies aim to control long-lived plasma cells involved in autoantibody production.
Immune Balance
Precision cellular therapies focus on restoring immune tolerance while maintaining healthy immune activity.
Next Generation CAR-T Strategies
CD19 CAR-T Cells
Engineered T cells targeting CD19-positive B cells represent one of the most studied approaches in autoimmune cellular therapy research.
CAAR-T Technology
Chimeric AutoAntigen Receptor T cells are designed to recognize specific autoreactive immune cells.
CAR-Tregs
CAR-modified regulatory T cells provide tissue-focused immune regulation and support immune tolerance research.
mRNA CAR-T
Temporary CAR expression using mRNA platforms offers flexibility, controlled activation, and innovative cellular engineering possibilities.
Safety & Future Development
Researchers continue improving CAR-T platforms through enhanced antigen selection, optimized CAR designs, advanced manufacturing methods, and personalized immune profiling. Future developments include universal CAR-T platforms, AI-assisted target discovery, and improved accessibility.